BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hsieh CB, Chen TW, Chu CM, Chu HC, Yu CP, Chung KP. Is inconsistency of α-fetoprotein level a good prognosticator for hepatocellular carcinoma recurrence? World J Gastroenterol 2010; 16(24): 3049-3055 [PMID: 20572309 DOI: 10.3748/wjg.v16.i24.3049]
URL: https://www.wjgnet.com/1007-9327/full/v16/i24/3049.htm
Number Citing Articles
1
A N L L Lalisang, W S Jeo, Y Moenadjat, T J M Lalisang. Correlation Between Serum Level of Alpha-Fetoprotein and Histological Differentiation Grade of Hepatocellular CarcinomaJournal of Physics: Conference Series 2018; 1073: 032056 doi: 10.1088/1742-6596/1073/3/032056
2
Cedric Badowski, Bing He, Lana X. Garmire. Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good, the Bad and the Beautynpj Precision Oncology 2022; 6(1) doi: 10.1038/s41698-022-00283-7
3
Guanghua Liu, Kui Wang, Jun Li, Yong Xia, Lihua Lu, Xuying Wan, Zhenlin Yan, Lehua Shi, Wan Yee Lau, Mengchao Wu, Feng Shen. Changes in serum alpha fetoprotein in patients with recurrent hepatocellular carcinoma following hepatectomyJournal of Gastroenterology and Hepatology 2015; 30(9): 1405 doi: 10.1111/jgh.12953
4
I. Popescu. Hepatocellular carcinoma – new trendsmemo - Magazine of European Medical Oncology 2010; 3(3): 113 doi: 10.1007/s12254-010-0220-9
5
Meng-Hsing Ho, Chih-Yung Yu, Kuo-Piao Chung, Teng-Wei Chen, Heng-Cheng Chu, Chih-Kung Lin, Chung-Bao Hsieh. Locoregional Therapy-Induced Tumor Necrosis as a Predictor of Recurrence after Liver Transplant in Patients with Hepatocellular CarcinomaAnnals of Surgical Oncology 2011; 18(13): 3632 doi: 10.1245/s10434-011-1803-3
6
Nagwan M. Abdel Samee. Classical and Deep Learning Paradigms for Detection and Validation of Key Genes of Risky Outcomes of HCVAlgorithms 2020; 13(3): 73 doi: 10.3390/a13030073
7
Junwei Tang, Runqiu Jiang, Lei Deng, Xudong Zhang, Ke Wang, Beicheng Sun. Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinomaOncotarget 2015; 6(6): 4505 doi: 10.18632/oncotarget.2934
8
Linda L. Wong, Willscott E. Naugler, Jonathan Schwartz, David L. Scott, Renuka Bhattacharya, Jorge Reyes, Susan L. Orloff. Impact of locoregional therapy and alpha‐fetoprotein on outcomes in transplantation for liver cancer: a UNOS Region 6 pooled analysisClinical Transplantation 2013; 27(1) doi: 10.1111/ctr.12056
9
Isidoro Di Carlo, Maurizio Mannino, Adriana Toro, Annalisa Ardiri, Antonio Galia, Giovanni Cappello, Gaetano Bertino. Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literatureWorld Journal of Surgical Oncology 2012; 10(1) doi: 10.1186/1477-7819-10-79
10
Experimental and Clinical Transplantation 2017; 15(Suppl 2) doi: 10.6002/ect.TOND16.L5